Sub Menu Area
Program
Contents Area
Scientific Program
ASGO 2019
"Optimal Gynecologic Cancer Care in Asia"
*Program is subject to change.
| Time | Program | Speaker |
|---|---|---|
| Shingo Fujii Medical Academy (270 min) | ||
Organizer: Shingo Fujii (Kyoto University, Japan) |
||
| 08:00-08:05 | Introduction of Shingo Fujii |
Soon-Beom Kang |
08:05-08:40 |
Robot-assisted laparoscopic nerve sparing radical hysterectomy and bilateral pelvic lymphadenectomy for early cervical cancer |
Wu-Chou Lin |
08:40-09:15 |
Surgical anatomy of para-vesico vaginal space |
Rongyu Zang |
09:15-09:50 |
Example video for discussion |
|
09:50-10:25 |
Anatomy of the posterior–leaf of the vesicouterine ligament |
Tetsu Asai & Mikio Mikami |
10:25-10:45 |
Break | |
10:45-11:20 |
Preservation of rectal branches of Inferior hypogastric plexus during resection of rectovaginal ligament |
Yoon Soon Lee |
11:20-11:55 |
Nerve-sparing radical hysterectomy |
Yasushi Kotani |
11:55-12:30 |
Anatomy and procedure performed safely of the vesicouterine ligament |
Kentaro Sekiyama |
| [Special Symposium 1] Sponsored by Astrazeneca (20 min) | Chair: Jong-Hyeok Kim (Korea) | |
| 12:35-12:55 | Evolving of BRCA mutated ovarian cancer treatment: study 19 | Richard Penson (USA) |
| [Opening Ceremony] (20 min) | ||
| 13:25-13:28 | Opening remarks | Seung Cheol Kim (Korea) |
| 13:28-13:31 | Congratulatory remarks | Hee-Sug Ryu (Korea) |
| [Plenary Session 1] President Invited Lectures (60 min) | Chair: Hee-Sug Ryu (Korea) Co-chair: Ikuo Konishi (Japan) |
|
| 13:45-14:15 | Toward precision medicine: evolution of global distributed research network in Korea | Rae-Woong Park (Korea) |
| 14:15-14:45 | Artificial intelligence in medicine | Yoon-Sup Choi (Korea) |
| [Shingo Fujii Medical Academy] (70 min) | ||
12:35-13:45 |
Luncheon & Opening Ceremony |
|
13:45-14:20 |
Reduced-port laparoscopic nerve sparing (type C1) radical hysterectomy |
Dae-Yeon Kim |
14:20-14:55 |
A modified technique for nerve-sparing radical hysterectomy |
Kittipat Charoenkwan |
| [Symposium 1] Rare Gynecologic Cancers: What is New? (90 min) | Chair: Hextan Ngan (Hong Kong) Co-chair: Taek-Sang Lee (Korea) |
|
| 15:05-15:20 | Ovarian clear cell carcinoma | Wen-Yee Chay (Singapore) |
| 15:20-15:35 | Uterine leiomyosarcoma | E Sun Paik (Korea) |
| 15:35-15:50 | Trophoblastic disease update | Yang Xiang (China) |
| 15:50-16:05 | Germ cell tumor | Hiroyuki Fujiwara (Japan) |
| 16:05-16:20 | Low grade serous carcinoma | Miseon Kim (Korea) |
| 16:20-16:35 | Discussion | |
| [Education Session 1] Radiation Gynecologic Oncology (90 min) | Chair: Joo-Young Kim (Korea) Co-chair: Won Park (Korea) |
|
| 15:05-15:25 | Locally advanced cervical cancer with lymph node positive on image: chemoradiation first? | Hyun-Cheol Kang (Korea) |
| 15:25-15:45 | What is the best sequence of chemotherapy and radiotherapy in locoregionally advanced endometrial cancer? | Jihye Cha (Korea) |
| 15:45-16:05 | The role of brachytherapy in the treatment of cervical cancer | Chomporn Sitathanee (Thailand) |
| 16:05-16:25 | MRI-guided brachytherapy in cervical cancer in Korea | Yeon Joo Kim (Korea) |
| 16:25-16:35 | Discussion | |
| [Oral 1] Cervical Cancer Screening/CIN (90 min) | Chair: Jae Yun Song (Korea) Co-chair: Tae Joong Kim (Korea) |
|
| 15:05-15:15 | Identification of key genes and microRNAs in cervical cancer progression by integrated bioinformatics analysis | Yuqin Zang (China) |
| 15:15-15:25 | The distribution and prevalence of high-risk human papillomavirus of women in western China: a meta-analysis | Mengpei Zhang (China) |
| 15:25-15:35 | Differences in the results of evaluation of quality assurance between the two methods of provision of population-based cervical cancer screening in Japan | Eiko Aoki (Japan) |
| 15:35-15:45 | A prospective randomized controlled study to compare thermal ablation with cryotherapy in cervical cancer screening | Dipanwita Banerjee (India) |
| 15:45-15:55 | Application of TERC and P16 FISH in triage of ASCUS | Ying Li (China) |
| 15:55-16:05 | Risk factors for type-specific HPV persistence after conization | Yung-Taek Ouh (Korea) |
| 16:05-16:15 | Abnormal endocervical curettage (ECC) result is an independent risk factor of positive margins in conization specimen | Jian An (China) |
| 16:15-16:25 | GX-188E, a therapeutic HPV vaccine, in combination with imiquimod or IL-7-HYFC for treatment of HPV-16 or HPV-18 related cin 3: results from phase 2 study | Sungjong Lee (Korea) |
| 16:25-16:35 | Quality assessment of websites providing information on HPV vaccines in Thailand | Naratassapol Likitdee (Thiland) |
| [Symposium 2] Cervical Cancer Screening in Asia (90 min) | Chair: Jae-Kwan Lee (Korea) Co-chair: Eiko Aoki (Japan) |
|
| 16:55-17:10 | The distribution and prevalence of human papillomavirus in women in mainland China | Rutie Yin (China) |
| 17:10-17:25 | Korean national cervical cancer screening program | Mina Suh (Korea) |
| 17:25-17:40 | Japanese population-based cervical cancer management system | Kumiko Saika (Japan) |
| 17:40-17:55 | Cervical cancer screening in India | Seema Singhal (India) |
| 17:55-18:10 | Cervical cancer screening in Myanmar | Myint Myint Thinn (Myanmar) |
| 18:10-18:25 | Discussion | |
| [Education Session 2] Gyne-Oncologic Pathology (90 min) | Chair: Hidetaka Katabuchi (Japan) Co-chair: Yong-Beom Kim (Korea) |
|
| 16:55-17:15 | Squamous cell carcinoma of the vulva and its precursors: does p53/p16 status matter? | Kyu-Rae Kim (Korea) |
| 17:15-17:35 | Mucinous ovarian tumor and pseudomyxoma | Chong Woo Yoo (Korea) |
| 17:35-17:55 | Molecular pathology and immunohistochemistry of gynecologic malignancy | Daichi Maeda (Japan) |
| 17:55-18:15 | Pathology of ovarian cancer precursors | Ren Chin Wu (Taiwan) |
| 18:15-18:25 | Discussion | |
| [Oral 2] Endometrial Hyperplasia/Cancer (80 min) | Chair: Jaeman Bae (Korea) Co-chair: Sungjong Lee (Korea) |
|
| 16:55-17:05 | Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean gynecologic oncology group study | Mi Kyoung Kim (Korea) |
| 17:05-17:15 | Diagnostic accuracy of MPap™ in women with abnormal uterine bleeding for endometrial cancer: preliminary report of a multicenter validating confirmatory study | Hung-Cheng Lai (Taiwan) |
| 17:15-17:25 | The effect of combined progesterone and GnRH agonist on the growth of endometrial cancer cells | Kyungjoo Cho (Korea) |
| 17:25-17:35 | Effect of megestrol acetate plus metformin as fertility-sparing treatment for patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer. A randomized controlled trial | Bingyi Yang (China) |
| 17:35-17:45 | The oncologic outcome after long term fertility-sparing hormonal management for early stage endometrioid endometrial cancer | Su Hyun Chae (Korea) |
| 17:45-17:55 | Prolactin enhances the proliferation of endometrial glandular cells and endometrial cancer cells in conjunction with estradiol via regulation of prolactin receptor and estrogen receptor | Munekage Yamaguchi (Japan) |
| 17:55-18:05 | Selecting endometrial cancer patients for high risk of recurrence | Ming-Yin Lin (Australia) |
| 18:05-18:15 | Using deep learning with convolutional neural network approach to identify the invasion depth of myometrium under MR images in early stage of endometrial cancer ~ a pilot study of TSGH in Taiwan | Cheng-Chang Chang (Taiwan) |